How do GLP-1 agonists compare against other strategies for weight reduction and cancer risk reduction? Elizabeth Tracey reports

For some types of cancer obesity is clearly a risk factor. Now a new study shows that when people with obesity take a GLP-1 agonist to lose weight, they also reduce their risk for these cancers. Kimmel Cancer Center director … How do GLP-1 agonists compare against other strategies for weight reduction and cancer risk reduction? Elizabeth Tracey reports Read more →